Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Sirolimus × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myelodysplastic Syndromes 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Hodgkin Disease 14 Lymphoma, Mantle-Cell 13 Leukemia, Myeloid, Acute 13 Multiple Myeloma 12 Graft vs Host Disease 12 Waldenstrom Macroglobulinemia 11 Lymphoma 11 Leukemia 11 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 10 Lymphoma, B-Cell, Marginal Zone 10 Sarcoma 9 Myeloproliferative Disorders 9 Burkitt Lymphoma 9 Tuberous Sclerosis 7 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Congenital Abnormalities 6 Breast Neoplasms 6 Lymphoma, Large-Cell, Anaplastic 5 Lymphangioleiomyomatosis 5 Leukemia, Myeloid, Chronic-Phase 5

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 13 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡